1. General
  2. Others

  3. Others

Cipla cuts prices on 3 anti-cancer drugs: reports

India Infoline News Service | Mumbai | November 08, 2012 12:51 IST

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

Drug maker Cipla has reduced the prices on three anti-cancer drugs Erlotinib (ERLOCIP), Docetaxel (DOCETAX) and Capecitabine (CAPEGARD), according to reports.

Reports stated that these drugs are for the treatment of lung and pancreatic cancer, breast cancer, head & neck cancer, gastric cancer, bladder, colorectal and colon cancers.

BSE 667.10 16.55(2.54%)
NSE 666.55 15.95(2.45%)
As on: 01 Jan 70, 05:30

***Note: This is a BSE Chart









 

 
 
 
Recent Reports
News